Efficacy of Daily Intranasal Palivizumab in Preventing Respiratory Syncytial Virus Infection in Healthy Preterm Infants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
eClinicalMedicine